Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.
Saved in:
| Title: | Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort. |
|---|---|
| Authors: | Mallet, J. (AUTHOR), Le Strat, Y. (AUTHOR), Schürhoff, F. (AUTHOR), Mazer, N. (AUTHOR), Portalier, C. (AUTHOR), Andrianarisoa, M. (AUTHOR), Aouizerate, B. (AUTHOR), Berna, F. (AUTHOR), Brunel, L. (AUTHOR), Capdevielle, D. (AUTHOR), Chereau, I. (AUTHOR), D'Amato, T. (AUTHOR), Dubreucq, J. (AUTHOR), Faget, C. (AUTHOR), Gabayet, F. (AUTHOR), Honciuc, R. M. (AUTHOR), Lançon, C. (AUTHOR), Llorca, P. M. (AUTHOR), Misdrahi, D. (AUTHOR), Rey, R. (AUTHOR) |
| Source: | European Archives of Psychiatry & Clinical Neuroscience. Jun2019, Vol. 269 Issue 4, p449-457. 9p. 2 Charts. |
| Subjects: | Smoking, Alcohol drinking, Antipsychotic agents, Schizophrenia, Neuroleptic malignant syndrome, Tobacco use |
| Abstract: | Tobacco smoking is common in schizophrenia and is one of the main causes of premature mortality in this disorder. Little is known about clinical correlates and treatments associated with tobacco smoking in patients with schizophrenia. Still, a better characterization of these patients is necessary, in a personalized care approach. Aggressiveness and childhood trauma have been associated with tobacco smoking in general population, but this association has never been explored in schizophrenia. Our study examines the clinical and therapeutic characteristics of tobacco smoking in schizophrenia. 474 stabilized patients (mean age = 32.2; 75.7% male gender; smokers n = 207, 54.6%) were consecutively included in the network of the FondaMental Expert centers for Schizophrenia and assessed with valid scales. Current tobacco status was self-declared. Aggressiveness was self-reported with Buss–Perry Aggressiveness Questionnaire and Childhood Trauma with Childhood Trauma Questionnaire. Ongoing treatment was reported. In univariate analysis, tobacco smoking was associated with lower education level (p < 0.01), positive syndrome (p < 0.01), higher physical aggressiveness (p < 0.001), alcohol dependence (p < 0.001), and First Generation Antipsychotics (FGAs) use (p = 0.018). In a multivariate model, tobacco smoking remained associated with physical aggressiveness (p < 0.05), current alcohol dependence (p < 0.01) and FGA use (p < 0.05). No association was observed with childhood trauma history, mood disorder, suicidal behavior, psychotic symptom, global functioning or medication adherence. Patients with tobacco use present clinical and therapeutic specificities, questioning the neurobiological links between tobacco and schizophrenia. They could represent a specific phenotype, with specific clinical and therapeutic specificities that may involve interactions between cholinergic–nicotinic system and dopaminergic system. Further longitudinal studies are needed to confirm the potential efficacy of second generation antipsychotics (SGAs) on tobacco use in schizophrenia and to develop effective strategies for tobacco cessation in this population. [ABSTRACT FROM AUTHOR] |
| Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 136523955 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mallet%2C+J%2E%22">Mallet, J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Le+Strat%2C+Y%2E%22">Le Strat, Y.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schürhoff%2C+F%2E%22">Schürhoff, F.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mazer%2C+N%2E%22">Mazer, N.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Portalier%2C+C%2E%22">Portalier, C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Andrianarisoa%2C+M%2E%22">Andrianarisoa, M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aouizerate%2C+B%2E%22">Aouizerate, B.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berna%2C+F%2E%22">Berna, F.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brunel%2C+L%2E%22">Brunel, L.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Capdevielle%2C+D%2E%22">Capdevielle, D.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chereau%2C+I%2E%22">Chereau, I.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22D'Amato%2C+T%2E%22">D'Amato, T.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dubreucq%2C+J%2E%22">Dubreucq, J.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Faget%2C+C%2E%22">Faget, C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gabayet%2C+F%2E%22">Gabayet, F.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Honciuc%2C+R%2E+M%2E%22">Honciuc, R. M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lançon%2C+C%2E%22">Lançon, C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Llorca%2C+P%2E+M%2E%22">Llorca, P. M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Misdrahi%2C+D%2E%22">Misdrahi, D.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rey%2C+R%2E%22">Rey, R.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Archives+of+Psychiatry+%26+Clinical+Neuroscience%22">European Archives of Psychiatry & Clinical Neuroscience</searchLink>. Jun2019, Vol. 269 Issue 4, p449-457. 9p. 2 Charts. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Smoking%22">Smoking</searchLink><br /><searchLink fieldCode="DE" term="%22Alcohol+drinking%22">Alcohol drinking</searchLink><br /><searchLink fieldCode="DE" term="%22Antipsychotic+agents%22">Antipsychotic agents</searchLink><br /><searchLink fieldCode="DE" term="%22Schizophrenia%22">Schizophrenia</searchLink><br /><searchLink fieldCode="DE" term="%22Neuroleptic+malignant+syndrome%22">Neuroleptic malignant syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22Tobacco+use%22">Tobacco use</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Tobacco smoking is common in schizophrenia and is one of the main causes of premature mortality in this disorder. Little is known about clinical correlates and treatments associated with tobacco smoking in patients with schizophrenia. Still, a better characterization of these patients is necessary, in a personalized care approach. Aggressiveness and childhood trauma have been associated with tobacco smoking in general population, but this association has never been explored in schizophrenia. Our study examines the clinical and therapeutic characteristics of tobacco smoking in schizophrenia. 474 stabilized patients (mean age = 32.2; 75.7% male gender; smokers n = 207, 54.6%) were consecutively included in the network of the FondaMental Expert centers for Schizophrenia and assessed with valid scales. Current tobacco status was self-declared. Aggressiveness was self-reported with Buss–Perry Aggressiveness Questionnaire and Childhood Trauma with Childhood Trauma Questionnaire. Ongoing treatment was reported. In univariate analysis, tobacco smoking was associated with lower education level (p < 0.01), positive syndrome (p < 0.01), higher physical aggressiveness (p < 0.001), alcohol dependence (p < 0.001), and First Generation Antipsychotics (FGAs) use (p = 0.018). In a multivariate model, tobacco smoking remained associated with physical aggressiveness (p < 0.05), current alcohol dependence (p < 0.01) and FGA use (p < 0.05). No association was observed with childhood trauma history, mood disorder, suicidal behavior, psychotic symptom, global functioning or medication adherence. Patients with tobacco use present clinical and therapeutic specificities, questioning the neurobiological links between tobacco and schizophrenia. They could represent a specific phenotype, with specific clinical and therapeutic specificities that may involve interactions between cholinergic–nicotinic system and dopaminergic system. Further longitudinal studies are needed to confirm the potential efficacy of second generation antipsychotics (SGAs) on tobacco use in schizophrenia and to develop effective strategies for tobacco cessation in this population. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=136523955 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00406-018-0873-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 449 Subjects: – SubjectFull: Smoking Type: general – SubjectFull: Alcohol drinking Type: general – SubjectFull: Antipsychotic agents Type: general – SubjectFull: Schizophrenia Type: general – SubjectFull: Neuroleptic malignant syndrome Type: general – SubjectFull: Tobacco use Type: general Titles: – TitleFull: Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mallet, J. – PersonEntity: Name: NameFull: Le Strat, Y. – PersonEntity: Name: NameFull: Schürhoff, F. – PersonEntity: Name: NameFull: Mazer, N. – PersonEntity: Name: NameFull: Portalier, C. – PersonEntity: Name: NameFull: Andrianarisoa, M. – PersonEntity: Name: NameFull: Aouizerate, B. – PersonEntity: Name: NameFull: Berna, F. – PersonEntity: Name: NameFull: Brunel, L. – PersonEntity: Name: NameFull: Capdevielle, D. – PersonEntity: Name: NameFull: Chereau, I. – PersonEntity: Name: NameFull: D'Amato, T. – PersonEntity: Name: NameFull: Dubreucq, J. – PersonEntity: Name: NameFull: Faget, C. – PersonEntity: Name: NameFull: Gabayet, F. – PersonEntity: Name: NameFull: Honciuc, R. M. – PersonEntity: Name: NameFull: Lançon, C. – PersonEntity: Name: NameFull: Llorca, P. M. – PersonEntity: Name: NameFull: Misdrahi, D. – PersonEntity: Name: NameFull: Rey, R. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 09401334 Numbering: – Type: volume Value: 269 – Type: issue Value: 4 Titles: – TitleFull: European Archives of Psychiatry & Clinical Neuroscience Type: main |
| ResultId | 1 |